Back To: Home

Our 2017 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
May 2017
TSRI research says small-molecule RNA inhibitors can target and kill specific types of cancer...
by Mel J. Yeates
May 2017
PARP inhibitors may be able to treat more breast cancer subtypes than previously thought...
by Rachel Flehinger
May 2017
Preclinical trial of CK-2127107 shows improved muscle function in mouse models of spinal muscular atrophy...
by Lori Lesko
May 2017
CRISPR/Cas9 gene-editing technology continues to make strides in life sciences...
by Jeffrey Bouley
Top Story
Q&A: The ethics of germline editing
Cambridge BioMarketing's Dr. Sam Falsetti discusses CRISPR/Cas9 in rare diseases and possibilities for the technology in somatic cell vs. germline editing

Patent Docs: Laches as a defense to patent infringement felled by Supreme Court
Decision raises the level of diligence drug companies must maintain to best avoid facing patent infringement suits at times when a drug has reached maximum profitability

Editor's Focus:
May 2017
The associate director in the Product Management group at Taconic Biosciences takes a look at where CRISPR has been, where it is now, where it is going and what that could all mean for getting the most out of this popular gene-editing technology.. [ more ]
by Dr. Adriano Flora

May 2017
Regardless of whether it's passive neglect or active erasure, we need to stop leaving out non-Caucasian populations when it comes to cancer research, genome studies and treatment.. [ more ]
by Randall C Willis

May 2017
It is good news that NIH, FDA and CDC all got funding boosts in the latest omnibus appropriations legislation, but that should be a foregone conclusion, not something we have to wonder about each and every year.. [ more ]
by Jeffrey Bouley

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.